Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 51 min ago
Peer-reviewedCC BY-NC 4.0Journal of Inflammation Research

CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer

4 affiliations
  1. 1Department of Thyroid Surgery, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China
  2. 2Department of Breast and Thyroid Surgery, The Central Hospital of Xiaogan & Xiaogan Hospital Affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei, 432100, People’s Republic of China
  3. 3Department of General Surgery (Breast Surgery), The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, 646000, People’s Republic of China
  4. 4School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, 430065, People’s Republic of China

Abstract

Background: CD97 is overexpressed in various cancers, but its function and immunoregulatory role in triple-negative breast cancer (TNBC) remain unclear. This study aimed to investigate the expression, function, and potential regulatory mechanisms of CD97 in TNBC.

Methods: CD97 expression, clinical associations, and immune infiltration were evaluated using TCGA, KM Plotter, and GEO bulk, single-cell, and spatial transcriptomic datasets. THP-1-derived M1a/M1b macrophage models with CD97 knockdown or overexpression were used to assess phagocytosis, cytokine secretion, and effects on tumor and endothelial cells. Zinc modulation, NF-κB inhibition, Western blotting, pseudotime analysis, transcription-factor screening, and network analyses were used to explore potential mechanisms.

Results: CD97 was upregulated in TNBC and enriched in M1 macrophages. In a pooled KM Plotter analysis, high CD97 expression was associated with favorable relapse-free survival; however, CD97 was not significantly associated with overall survival in the TCGA-TNBC cohort in univariable or stage-adjusted Firth Cox analyses. In M1a macrophages, CD97 perturbation altered phagocytic activity, tumor-cell apoptosis, intracellular zinc homeostasis, and NF-κB signaling, with pharmacological inhibition supporting NF-κB as a downstream mediator. In M1b macrophages, CD97 knockdown increased, whereas overexpression decreased, MDA-MB-231 migration and invasion in vitro. SPI1 perturbation altered CD97 expression, supporting SPI1 as a potential upstream regulator rather than establishing direct transcriptional control.

Conclusion: CD97 is associated with immune-active features in TNBC and modulates macrophage functions in vitro. Its prognostic relevance appears context- and dataset-dependent, and further in vivo and clinical validation is required before translational application.

Related

  1. Trichomonas vaginalis-shaped inflammatory microenvironment drives macrophage immune signaling and modulates cervical cancer cell proliferation and migration
    Ching-Yun Huang, Ya-Wen Shih, Chi-Hong Ho +6
    Parasites & VectorsPeer-reviewedCC BY 4.0Full textImmunologyPMC
  2. TMEM189/PEDS1 deficiency aggravates MASH progression by promoting FASN-mediated macrophage activation
    Pengli Guo, Jinqiu Feng, Yaxin Lou +7
    Cell Death & DiseasePeer-reviewedCC BY 4.0Full textGeneral biochemistryCell biologyPMCDOAJ
  3. Macrophage- or neutrophil-expressed UPP1 drives tumor growth and immune suppression in the tumor microenvironment
    Yin Li, Qin Ran, Anying Xiong +7
    Science advancesPeer-reviewedCC BY-NCFull textImmunologyEurope PMCCrossref
  4. Integrated in silico and 3D in vitro model of macrophage migration in response to physical and chemical factors in the tumor microenvironment
    Sharon Wei Ling Lee, R.J. Seager, Felix Litvak +9
    Integrative BiologyPreprintLicence not statedImmunologyHAL
  5. Membrane Cholesterol Efflux Drives Tumor-Associated Macrophage Reprogramming and Tumor Progression
    Pieter Goossens, Juan Rodriguez-Vita, Anders Etzerodt +14
    Cell MetabolismPeer-reviewedLicence not statedFull text539 citedImmunologyHAL
BibTeX
@article{peng2026cd97,
  title = {{CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer}},
  author = {Pai Peng and Peng Zhou and Zitao Liu and Haoyuan Shen and Chaohua Hu and Jun Jiang},
  journal = {Journal of Inflammation Research},
  year = {2026},
  month = nov,
  doi = {10.2147/jir.s620455},
  url = {https://doi.org/10.2147/jir.s620455},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - CD97 Modulates M1-Like Macrophage Activation and Function to Influence the Immune Microenvironment and Tumor Progression in Triple-Negative Breast Cancer
AU  - Pai Peng
AU  - Peng Zhou
AU  - Zitao Liu
AU  - Haoyuan Shen
AU  - Chaohua Hu
AU  - Jun Jiang
PY  - 2026
DA  - 2026/11/05
JO  - Journal of Inflammation Research
DO  - 10.2147/jir.s620455
UR  - https://doi.org/10.2147/jir.s620455
AB  - Background: CD97 is overexpressed in various cancers, but its function and immunoregulatory role in triple-negative breast cancer (TNBC) remain unclear. This study aimed to investigate the expression, function, and potential regulatory mechanisms of CD97 in TNBC.  Methods: CD97 expression, clinical associations, and immune infiltration were evaluated using TCGA, KM Plotter, and GEO bulk, single-cell, and spatial transcriptomic datasets. THP-1-derived M1a/M1b macrophage models with CD97 knockdown or overexpression were used to assess phagocytosis, cytokine secretion, and effects on tumor and endothelial cells. Zinc modulation, NF-κB inhibition, Western blotting, pseudotime analysis, transcription-factor screening, and network analyses were used to explore potential mechanisms.  Results: CD97 was upregulated in TNBC and enriched in M1 macrophages. In a pooled KM Plotter analysis, high CD97 expression was associated with favorable relapse-free survival; however, CD97 was not significantly associated with overall survival in the TCGA-TNBC cohort in univariable or stage-adjusted Firth Cox analyses. In M1a macrophages, CD97 perturbation altered phagocytic activity, tumor-cell apoptosis, intracellular zinc homeostasis, and NF-κB signaling, with pharmacological inhibition supporting NF-κB as a downstream mediator. In M1b macrophages, CD97 knockdown increased, whereas overexpression decreased, MDA-MB-231 migration and invasion in vitro. SPI1 perturbation altered CD97 expression, supporting SPI1 as a potential upstream regulator rather than establishing direct transcriptional control.  Conclusion: CD97 is associated with immune-active features in TNBC and modulates macrophage functions in vitro. Its prognostic relevance appears context- and dataset-dependent, and further in vivo and clinical validation is required before translational application.
SN  - 1178-7031
ER  -